Human umbilical cord mesenchymal stem cell-derived exosomes (Qilu Cell Therapy)
人脐带间充质干细胞来源外泌体（齐鲁细胞）
Report date: 2025/04/02 13:36:22
Base Information
Drug NameHuman umbilical cord mesenchymal stem cell-derived exosomes (Qilu Cell Therapy)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A